Metraipolis › archive › dc_c68ab23daeeb

11-Methoxyasimilobine — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/11-Methoxyasimilobine
License (as archived)
CC-BY-SA-4.0
Archived
2026-10-07T15:55:22.092Z
SHA-256 of the archived text
cedcb7f7e10bf49aca6286028495b17a82f9d93e3fae4e2682c74b4cf6d99aa2
Stable URL of this page
https://metraipolis.com/documento/dc_c68ab23daeeb

How to cite

11-Methoxyasimilobine — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/11-Methoxyasimilobine (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_c68ab23daeeb (Metraipolis archive dc_c68ab23daeeb, sha256 cedcb7f7e10bf49aca6286028495b17a82f9d93e3fae4e2682c74b4cf6d99aa2)
BibTeX
@misc{dcc68ab23daeeb,
  title = {11-Methoxyasimilobine — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/11-Methoxyasimilobine},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_c68ab23daeeb; sha256 cedcb7f7e10bf49aca6286028495b17a82f9d93e3fae4e2682c74b4cf6d99aa2},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/11-Methoxyasimilobine. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

11-Methoxyasimilobine, also known as 1,11-dimethoxy-2-hydroxynoraporphine, is a serotonin 5-HT2 receptor agonist of the noraporphine family related to the noraporphine alkaloid asimilobine. It is the 11-methoxy derivative of asimilobine. Whereas asimilobine is a selective, lower-potency, high-efficacy partial agonist of the serotonin 5-HT2C receptor, 11-methoxyasimilobine is a highly potent and selective full agonist of both the serotonin 5-HT2A and 5-HT2C receptors, with approximately 8-fold preferential activation of the serotonin 5-HT2C receptor over the serotonin 5-HT2A receptor. Its EC50Tooltip half-maximal effective concentration (EmaxTooltip maximal efficacy) values were 18 nM (98%) at the serotonin 5-HT2A receptor and 2.3 nM (100%) at the serotonin 5-HT2C receptor. The drug is a biased agonist of the serotonin 5-HT2C receptor, favoring Gq signaling over β-arrestin recruitment by approximately 6.3-fold. It was among the most potent dual serotonin 5-HT2A and 5-HT2C receptor agonists of a large series of assessed noraporphines. Besides the serotonin 5-HTA and 5-HT2C receptors, the drug also showed weak agonism of the serotonin 5-HT2B receptor, but only at very high concentrations (EC50 = >10,000 nM). It showed little activity at a selection of other serotonin receptors. The chemical synthesis of 11-methoxyasimilobine has been described. A variety of analogues of the drug with similar activity have also been described. 11-Methoxyasimilobine was described in the scientific literature by Wangzhi Qin and colleagues in 2025. It had previously been patented in 2022. There is interest in 11-methoxyasimilobine and related compounds for potential medical use, such as treatment of anxiety, obsessive–compulsive disorder (OCD), and substance use disorders.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «11-Methoxyasimilobine» — https://en.wikipedia.org/wiki/11-Methoxyasimilobine
Wikidata Q139500005 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q139500005
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/11-Methoxyasimilobine?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1350445230, consultata il 2026-10-07T15:28:32.041Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: b70143f152c1e577cd49633a72921722832c7963f4654099f066eccbd61b1f94